• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Cinchona alkaloids Cinchona alkaloids
• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Cinchona alkaloids

Cinchonine Hydrochloride (CAS No: 206986-88-1)

Cinchonine hydrochloride, a derivative of cinchona alkaloids, has garnered significant attention in the scientific community due to its diverse pharmacological properties. With the CAS registry number 206986-88-1, this compound is widely recognized for its role in various biological systems. Recent studies have highlighted its potential in the fields of antimicrobial therapy, anti-inflammatory treatments, and neuroprotective applications. The compound's unique chemical structure, which includes a quinoline skeleton, contributes to its ability to interact with multiple cellular pathways, making it a promising candidate for drug development.

The cinchona alkaloids family, to which cinchonine hydrochloride belongs, has been extensively studied for its bioactive properties. Researchers have identified that the compound exhibits antioxidant activity, which is crucial in combating oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular diseases. A 2023 study published in the *Journal of Natural Products* demonstrated that cinchonine hydrochloride significantly reduced reactive oxygen species (ROS) levels in vitro, indicating its potential as a therapeutic agent in oxidative stress-mediated conditions.

In addition to its antioxidant properties, cinchonine hydrochloride has shown remarkable anti-inflammatory effects. Inflammation is a key factor in chronic diseases such as arthritis, diabetes, and cancer. A recent investigation conducted by researchers at the University of California revealed that cinchonine hydrochloride inhibits the production of pro-inflammatory cytokines like TNF-α and IL-6. This finding underscores its potential as a novel anti-inflammatory drug with fewer side effects compared to conventional treatments.

The compound's neuroprotective properties have also been a focal point of recent research. Studies have shown that cinchonine hydrochloride can protect neurons from damage caused by amyloid-beta peptides, which are implicated in Alzheimer's disease. A 2023 study published in *Neuroscience Letters* reported that the compound enhances cognitive function in animal models by improving synaptic plasticity and reducing neuroinflammation. These findings suggest that cinchonine hydrochloride could be a valuable addition to the arsenal of drugs targeting neurodegenerative diseases.

Furthermore, cinchonine hydrochloride has demonstrated potent antimicrobial activity against various bacterial and fungal strains. With the increasing threat of antibiotic resistance, there is an urgent need for novel antimicrobial agents. A study conducted by researchers at the University of Oxford found that cinchonine hydrochloride exhibited strong inhibitory effects against multidrug-resistant strains of *Staphylococcus aureus* and *Escherichia coli*. This highlights its potential as an alternative to traditional antibiotics in combating infectious diseases.

The synthesis and characterization of cinchonine hydrochloride have also been optimized in recent years. Scientists have developed efficient methods for large-scale production of this compound, ensuring its availability for both research and therapeutic applications. The compound's stability under various storage conditions has been thoroughly investigated, making it suitable for formulation into tablets, capsules, or injectable forms.

In conclusion, cinchonine hydrochloride (CAS No: 206986-88-1) is a versatile compound with a wide range of biological activities. Its antioxidant, anti-inflammatory, neuroprotective, and antimicrobial properties make it a promising candidate for drug development across multiple therapeutic areas. As research continues to uncover new insights into its mechanisms of action and clinical applications, cinchonine hydrochloride is poised to play a significant role in advancing modern medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)